Gene expression analysis in transgenic SMA models, as well as in chronically denervated mice muscle and muscle tissue samples from SMA patients in our bioinformatic study supported a potential role for myostatin and follistatin as biomarkers for SMA. This evidence concerns the gene FST and proximal spinal muscular atrophy.